Opportunity knocking states: "Abbott and Inverness see recaf as a viable tool."
Does the following statement from the 8K amended agreement with Abbott sound like Abbott views RECAF as a viable tool?
<<Abbott shall have no further due diligence obligations whatsoever to commercialize or perform any further Research and Development on any Product as of the Second Amendment Date.>>
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.